NCT02170181View on ClinicalTrials.gov

Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

CompletedOBSERVATIONAL

Enrollment

149

Participants

Timeline

Start Date

May 28, 2014

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Cancer Patients Receiving Stereotactic Body RTX

Interventions

RADIATION

SBRT

SBRT to Oligometastases

Trial Locations (1)

75239

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER

NCT02170181 - Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation | Biotech Hunter | Biotech Hunter